Moreover, in ex vivo culture with 4T1 tumor supernatant, these miRNA-engineered HS/PCs were differentiated into CD11b+ myeloid cells (Fig. 2a), and GFP expression was observed in ~68% (Fig. 2b). The gene discussed is ITGAM; the disease is neoplasm.